UBS Group
PEPLW

UBS Group’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

UBS Group’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,444
Closed -$955 – 10256
2023
Q3 		$955 Buy
+13,444
New +$850 ﹤0.01% 8206
2022
Q3 		– Sell
-100
Closed – – 11224
2022
Q2 		$0 Buy
+100
New +$41 ﹤0.01% 11227

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

UBS Group's PEPLW Position: Q4 2023 in Review

UBS Group sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q4 2023, closing a stake of 13,444 shares — an estimated $955 sold.

UBS Group first reported a position in PEPLW in Q2 2022 and held it in 2 quarters. The position peaked at $955 in Q3 2023. 17 funds tracked by Wall St. Rank hold PEPLW as of Q4 2023.

  • UBS Group reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 13,444 PepperLime Health Acquisition Corporation Warrrant shares in Q4 2023, an estimated $955.
  • UBS Group first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q2 2022 and held it in 2 quarters.
  • UBS Group's PepperLime Health Acquisition Corporation Warrrant position peaked at $955 in Q3 2023.
  • 17 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.